BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20140438)

  • 1. Utility of NT-pro-BNP in patients undergoing transapical aortic valve replacement.
    Pfister R; Wahlers T; Baer FM; Scherner M; Strauch J; Erdmann E
    Clin Res Cardiol; 2010 May; 99(5):301-7. PubMed ID: 20140438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between prosthesis-patient mismatch and pro-brain natriuretic peptides after aortic valve replacement.
    Melina G; Angeloni E; Benedetto U; Refice S; Miceli A; Miele C; Ciavarella GM; Sinatra R
    J Heart Valve Dis; 2010 Mar; 19(2):171-6. PubMed ID: 20369499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of N-terminal-pro-brain natriuretic peptide with postoperative outcomes of older patients undergoing transcatheter aortic valve replacement.
    Huang YC; Chang HH; Chen PL; Chu CM; Tsai JC; Wang KY
    J Chin Med Assoc; 2023 May; 86(5):479-484. PubMed ID: 36930846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
    Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of B-type natriuretic peptides on long-term outcomes after transcatheter aortic valve implantation.
    Koskinas KC; O'Sullivan CJ; Heg D; Praz F; Stortecky S; Pilgrim T; Buellesfeld L; Jüni P; Windecker S; Wenaweser P
    Am J Cardiol; 2015 Nov; 116(10):1560-5. PubMed ID: 26428025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of diastolic dysfunction on long-term mortality and quality of life after transcatheter aortic valve replacement.
    Anantha-Narayanan M; Malik U; Mbai M; Megaly M; Florea V; Sharma A; Cavalcante JL; Garcia S
    Catheter Cardiovasc Interv; 2020 Apr; 95(5):1034-1041. PubMed ID: 31419009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different impact of aortic regurgitation assessed by aortic root angiography after transcatheter aortic valve implantation according to baseline left ventricular ejection fraction and N-terminal pro-B-type natriuretic peptide.
    Kaneko H; Hoelschermann F; Schau T; Tambor G; Neuss M; Butter C
    Cardiovasc Interv Ther; 2018 Jul; 33(3):232-238. PubMed ID: 28567700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-type natriuretic peptide is associated with remodeling and exercise capacity after transcatheter aortic valve replacement for aortic stenosis.
    Sato K; Kumar A; Krishnaswamy A; Mick S; Desai MY; Griffin BP; Kapadia SR; Popović ZB
    Clin Cardiol; 2019 Feb; 42(2):270-276. PubMed ID: 30565264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of forced expiratory volume in 1 s and N-terminal pro-B-type natriuretic peptide with outcomes after transcatheter aortic valve replacement.
    Crestanello JA; Greason KL; Mathew J; Eleid MF; Nkomo VT; Rihal CS; Bagameri G; Holmes DR; Pislaru SV; Sandhu GS; Lee AT; King KS; Alkhouli M
    Eur J Cardiothorac Surg; 2023 Apr; 63(4):. PubMed ID: 36645236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of N-Terminal Pro-form B-Type Natriuretic Peptide in Patients With Moderate Aortic Stenosis.
    Ito S; Miranda WR; Jaffe AS; Oh JK
    Am J Cardiol; 2020 May; 125(10):1566-1570. PubMed ID: 32204871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation.
    López-Otero D; Trillo-Nouche R; Gude F; Cid-Álvarez B; Ocaranza-Sanchez R; Alvarez MS; Lear PV; Gonzalez-Juanatey JR
    Int J Cardiol; 2013 Sep; 168(2):1264-8. PubMed ID: 23280329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.
    Iwahashi N; Nakatani S; Umemura S; Kimura K; Kitakaze M
    J Am Soc Echocardiogr; 2011 Sep; 24(9):984-91. PubMed ID: 21570253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early changes in N-terminal pro-B-type natriuretic peptide levels after transcatheter aortic valve replacement and its impact on long-term mortality.
    Liebetrau C; Gaede L; Kim WK; Arsalan M; Blumenstein JM; Fischer-Rasokat U; Wolter JS; Kriechbaum S; Huber MT; van Linden A; Berkowitsch A; Dörr O; Nef H; Hamm CW; Walther T; Möllmann H
    Int J Cardiol; 2018 Aug; 265():40-46. PubMed ID: 29885699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of brain natriuretic peptide levels in patients with severe aortic stenosis undergoing operative valve replacement or percutaneous transcatheter intervention with clinical, echocardiographic, and hemodynamic factors and prognosis.
    Ben-Dor I; Minha S; Barbash IM; Aly O; Dvir D; Deksissa T; Okubagzi P; Torguson R; Lindsay J; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2013 Aug; 112(4):574-9. PubMed ID: 23683951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery of left ventricular systolic longitudinal strain after valve replacement in aortic stenosis and relation to natriuretic peptides.
    Poulsen SH; Søgaard P; Nielsen-Kudsk JE; Egeblad H
    J Am Soc Echocardiogr; 2007 Jul; 20(7):877-84. PubMed ID: 17617315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between N-terminal pro-B type natriuretic peptide and extensive echocardiographic parameters in mild to moderate aortic stenosis.
    Cemri M; Arslan U; Kocaman SA; Cengel A
    J Postgrad Med; 2008; 54(1):12-6. PubMed ID: 18296798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Prognostic Value of High-Sensitivity Troponin T Added to N-Terminal Pro Brain Natriuretic Peptide Plasma Levels Before Valve Replacement for Severe Aortic Stenosis.
    Barbieri F; Senoner T; Adukauskaite A; Dobner S; Holfeld J; Semsroth S; Lambert T; Zweiker D; Theurl T; Rainer PP; Schmidt A; Feuchtner GM; Steinwender C; Hoppe UC; Hintringer F; Bauer A; Müller S; Grimm M; Pfeifer BE; Dichtl W
    Am J Cardiol; 2019 Dec; 124(12):1932-1939. PubMed ID: 31699359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of NT-pro BNP and CT-ANP as markers of concentric hypertrophy in dogs with a model of compensated aortic stenosis.
    Hori Y; Tsubaki M; Katou A; Ono Y; Yonezawa T; Li X; Higuchi SI
    J Vet Intern Med; 2008; 22(5):1118-23. PubMed ID: 18681918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic Utility of Brain Natriuretic Peptide and Left Ventricular Strain in Patients With Significant Aortic Stenosis.
    Goodman A; Kusunose K; Popovic ZB; Parikh R; Barr T; Sabik JF; Rodriguez LL; Svensson LG; Griffin BP; Desai MY
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26732551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natriuretic peptides in the management of aortic stenosis.
    Bergler-Klein J
    Curr Cardiol Rep; 2009 Mar; 11(2):85-93. PubMed ID: 19236823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.